Page last updated: 2024-08-25

rosiglitazone and Liver Failure

rosiglitazone has been researched along with Liver Failure in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbehenn, E; Floyd, JS; Lurie, P; Wolfe, SM1
Cobitz, AR; Kolatkar, NS; Koro, CE; Osei, SY; Stender, M1
Beiderbeck, AB; Sakaguchi, M1
Iyer, S; Perez, A; Rajagopalan, R1
Lai, MY; Su, DH; Wu, HP1
Diamond, RH; Forman, LM; Simmons, DA1
Boscia, J; Everitt, D; Freid, J1
Isley, WL; Oki, JC1
Gale, EA1
McMorran, M; Vu, D1
Cohen, RI; Gouda, HE; Khan, A; Schwartz, J1
Freed, MI; Kreider, M; Lebovitz, HE1

Reviews

1 review(s) available for rosiglitazone and Liver Failure

ArticleYear
Lessons from the glitazones: a story of drug development.
    Lancet (London, England), 2001, Jun-09, Volume: 357, Issue:9271

    Topics: Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Drug Approval; Drug Therapy, Combination; Europe; Humans; Hypoglycemic Agents; Liver Failure; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone; United States

2001

Trials

1 trial(s) available for rosiglitazone and Liver Failure

ArticleYear
Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.
    Diabetes care, 2002, Volume: 25, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Liver Failure; Liver Function Tests; Male; Metformin; Middle Aged; Reference Values; Rosiglitazone; Thiazoles; Thiazolidinediones

2002

Other Studies

10 other study(ies) available for rosiglitazone and Liver Failure

ArticleYear
Case series of liver failure associated with rosiglitazone and pioglitazone.
    Pharmacoepidemiology and drug safety, 2009, Volume: 18, Issue:12

    Topics: Adverse Drug Reaction Reporting Systems; Aged; Chemical and Drug Induced Liver Injury; Databases, Factual; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Liver Failure; Male; Middle Aged; Pioglitazone; Risk Factors; Rosiglitazone; Thiazolidinediones; Time Factors

2009
Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.
    Pharmacoepidemiology and drug safety, 2009, Volume: 18, Issue:12

    Topics: Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver Failure; Pioglitazone; Rosiglitazone; Thiazolidinediones

2009
Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al.
    Pharmacoepidemiology and drug safety, 2009, Volume: 18, Issue:12

    Topics: Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver Failure; Pioglitazone; Rosiglitazone; Thiazolidinediones

2009
Comparison of pioglitazone with other antidiabetic drugs for associated incidence of liver failure: no evidence of increased risk of liver failure with pioglitazone.
    Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemic Agents; Liver Failure; Male; Metformin; Middle Aged; Pioglitazone; Retrospective Studies; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones

2005
Liver failure in a patient receiving rosiglitazone therapy.
    Diabetic medicine : a journal of the British Diabetic Association, 2006, Volume: 23, Issue:1

    Topics: Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Liver Failure; Liver Function Tests; Middle Aged; Rosiglitazone; Thiazolidinediones

2006
Hepatic failure in a patient taking rosiglitazone.
    Annals of internal medicine, 2000, Jan-18, Volume: 132, Issue:2

    Topics: Aged; Combined Modality Therapy; Coronary Disease; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Hypoglycemic Agents; Ischemia; Liver; Liver Failure; Male; Monitoring, Physiologic; Pravastatin; Rosiglitazone; Thiazoles; Thiazolidinediones; Verapamil

2000
Rosiglitazone and hepatic failure.
    Annals of internal medicine, 2000, Jan-18, Volume: 132, Issue:2

    Topics: Coronary Disease; Humans; Hypoglycemic Agents; Ischemia; Liver; Liver Failure; Rosiglitazone; Thiazoles; Thiazolidinediones

2000
Rosiglitazone and liver failure.
    Annals of internal medicine, 2000, Sep-05, Volume: 133, Issue:5

    Topics: Humans; Liver Failure; Rosiglitazone; Thiazoles; Thiazolidinediones

2000
Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2001, Jul-10, Volume: 165, Issue:1

    Topics: Aged; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Female; Hematologic Diseases; Humans; Hypoglycemic Agents; Liver Failure; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones

2001
Liver failure in a patient treated with long-term rosiglitazone therapy.
    The American journal of medicine, 2001, Volume: 111, Issue:7

    Topics: Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Humans; Hypoglycemic Agents; Liver Failure; Male; Rosiglitazone; Thiazoles; Thiazolidinediones

2001